References

1. Traycoff CM, Kosak ST, Grigsby S, et al.: Evaluation of ex vivo expansion potential of cord blood and bone marrow hematopoietic progenitor cells using cell tracking and limiting dilution analysis. Blood 85:2059-2068, 1995.

2. Cairo MS, Law P, van de Ven C, et al.: The in vitro effects of stem cell factor and PIXY321 on myeloid progenitor formation (CFU-GM) from immunomagnetic separated CD34+ cord blood. Pediatr Res 32:277-281, 1992.

3. van de Ven C, Ishizawa L, Law P, et al.: IL-11 in combination with SLF and G-CSF or GM-CSF significantly increases expansion of isolated CD34+ cell population from cord blood vs. adult bone marrow. Exp Hematol 23:1289-1295, 1995.

4. Lu L, Xiao M, Shen RN, et al.: Enrichment, characterization, and responsiveness of single primitive CD34 human umbilical cord blood hematopoietic progenitors with high proliferative and replating potential. Blood 81:41-48, 1993.

5. Gluckman E, Broxmeyer HA, Auerbach AD, et al.: Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl J Med 321:1174-1178, 1989.

6. Kurtzberg J, Graham M, Casey J, et al.: The use of umbilical cord blood in mismatched related and unrelated hemopoietic stem cell transplantation. Blood Cells 20:275-283, 1994; discussion: 284.

7. Sanz MA, Sanz GF: Unrelated donor umbilical cord blood transplantation in adults. Leukemia 16:1984-1991, 2002.

8. Armitage JO: Bone marrow transplantation. N Engl J Med 330:827-838, 1994.

9. Confer D: Unrelated marrow donor registries. Curr Opin Hematol 4:408-412, 1997.

10. bmdw.org/Addresses/USA.html.

11. Burgio GR, Gluckman E, Locatelli F: Ethical reappraisal of 15 years of cord-blood transplantation. Lancet 361:250-252, 2003.

12. Sugarman J, Reisner EG, Kurtzberg J: Ethical aspects of banking placental blood for transplantation. JAMA 274:1783-1785, 1995.

13. Vawter DE, Rogers-Chrysler G, Clay M, et al.: A phased consent policy for cord blood donation. Transfusion 42:1268-1274, 2002.

14. Fraser JK, Cairo MS, Wagner EL, et al.: Cord Blood Transplantation Study (COBLT): cord blood bank standard operating procedures. JHematother 7:521-561, 1998.

15. Nakagawa R, Watanabe T, Kawano Y, et al.: Analysis of maternal and neonatal factors that influence the nucleated and CD34+ cell yield for cord blood banking. Transfusion 44:262-267, 2004.

16. Ballen KK, Wilson M, Wuu J, et al.: Bigger is better: maternal and neonatal predictors of hematopoietic potential of umbilical cord blood units. Bone Marrow Transplant 27:7-14, 2001.

17. Surbek DV, Schonfeld B, Tichelli A, et al.: Optimizing cord blood mononuclear cell yield: a randomized comparison of collection before vs after placenta delivery. Bone Marrow Transplant 22:311-312, 1998.

18. Solves P, Moraga R, Saucedo E, et al.: Comparison between two strategies for umbilical cord blood collection. Bone Marrow Transplant 31:269-273, 2003.

19. Lasky LC, Lane TA, Miller JP, et al.: In utero or ex utero cord blood collection: which is better? Transfusion 42: 1261-1267, 2002.

20. Bertolini F, Battaglia M, Zibera C, et al.: A new method for placental/cord blood processing in the collection bag. I: Analysis of factors involved in red blood cell removal. Bone Marrow Transplant 18:783-786, 1996.

21. Nagler A, Peacock M, Tantoco M, et al.: Separation of hematopoietic progenitor cells from human umbilical cord blood. J Hematother 2:243-245, 1993.

22. Harris DT, Schumacher MJ, Rychlik S, et al.: Collection, separation and cryopreservation of umbilical cord blood for use in transplantation. Bone Marrow Transplant 13:135-143, 1994.

23. Sousa T, de Sousa ME, Godinho MI, et al.: Umbilical cord blood processing: volume reduction and recovery of CD34+ cells. Bone Marrow Transplant 19:311-313, 1997.

24. Armitage S, Fehily D, Dickinson A, et al.: Cord blood banking: volume reduction of cord blood units using a semi-automated closed system. Bone Marrow Transplant 23:505-509, 1999.

25. M-Reboredo N, Diaz A, Castro A, et al.: Collection, processing and cryopreservation of umbilical cord blood for unrelated transplantation. Bone Marrow Transplant 26:1263-1270, 2000.

26. Rubinstein P, Dobrila L, Rosenfield RE, et al.: Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. Proc Natl Acad Sci USA 92:10119-10122, 1995.

27. Broxmeyer HE, Cooper S: High-efficiency recovery of immature haematopoietic progenitor cells with extensive proliferative capacity from human cord blood cry-opreserved for 10 years. Clin Exp Immunol 107(suppl 1): 45-53, 1997.

28. Barker JN, Krepski TP, DeFor TE, et al.: Searching for unrelated donor hematopoietic stem cells: availability and speed of umbilical cord blood versus bone marrow. Biol Blood Marrow Transplant 8:257-260, 2002.

29. Poli F, Scalamogna M, Crespiatico L, et al.: Comparison of serological and molecular typing for HLA-A and -B on cord blood lymphocytes. Tissue Antigens 51:67-71, 1998.

30. Laurenti L, Perrone MP, Bafti MS, et al.: HLA typing strategies in a cord blood bank. Haematologica 87: 851-854, 2002.

31. Risdon G, Gaddy J, Broxmeyer HE: Allogeneic responses of human umbilical cord blood. Blood Cells 20:566-570, 1994; discussion: 571-572.

32. Roncarolo MG, Bigler M, Ciuti E, et al.: Immune responses by cord blood cells. Blood Cells 20:573-585, 1994; discussion: 585-586.

33. Roux E, Helg C, Dumont-Girard F, et al.: Analysis of T-cell repopulation after allogeneic bone marrow transplantation: significant differences between recipients of T-cell depleted and unmanipulated grafts. Blood 87: 3984-3992, 1996.

34. Roux E, Helg C, Chapuis B, et al.: T-cell repertoire complexity after allogeneic bone marrow transplantation. Hum Immunol 48:135-138, 1996.

35. Dumont-Girard F, Roux E, van Lier RA. et al.: Reconstitution of the T-cell compartment after bone marrow transplantation: restoration of the repertoire by thymic emigrants. Blood 92:4464-4471, 1998.

36. Roux E, Dumont-Girard F, Starobinski M, et al.: Recovery of immune reactivity after T-cell-depleted bone marrow transplantation depends on thymic activity. Blood 96: 2299-2303, 2000.

37. Mackall CL, Granger L, Sheard MA, et al.: T-cell regeneration after bone marrow transplantation: differential CD45 isoform expression on thymic-derived versus thymic-independent progeny. Blood 82:2585-2594, 1993.

38. Theilgaard-Monch K, Raaschou-Jensen K, Schjodt K, et al.: Pluripotent and myeloid-committed CD34+ subsets in hematopoietic stem cell allografts. Bone Marrow Transplant 32:1125-1133, 2003.

39. Theilgaard-Monch K, Raaschou-Jensen K, Palm H, et al.: Flow cytometric assessment of lymphocyte subsets, lymphoid progenitors, and hematopoietic stem cells in allogeneic stem cell grafts. Bone Marrow Transplant 28: 1073-1082, 2001.

40. Bogue M, Roth DB: Mechanism of V(D)J recombination. Curr Opin Immunol 8:175-180, 1996.

41. Gorski J, Yassai M, Zhu X, et al.: Circulating T cell repertoire complexity in normal individuals and bone marrow recipients analyzed by CDR3 size spectratyp-ing. Correlation with immune status. J Immunol 152: 5109-5119, 1994.

42. Abu-Ghosh A, Goldman S, Slone V, et al.: Immunological reconstitution and correlation of circulating serum inflammatory mediators/cytokines with the incidence of acute graft-versus-host disease during the first 100 days following unrelated umbilical cord blood transplantation. Bone Marrow Transplant 24: 535-544, 1999.

43. Niehues T, Rocha V, Filipovich AH, et al.: Factors affecting lymphocyte subset reconstitution after either related or unrelated cord blood transplantation in children—a Eurocord analysis. Br J Haematol 114: 42-48, 2001.

44. Klein AK, Patel DD, Gooding ME, et al.: T-cell recovery in adults and children following umbilical cord blood transplantation. Biol Blood Marrow Transplant 7:454-466, 2001.

45. Talvensaari K, Clave E, Douay C, et al.: A broad T-cell repertoire diversity and an efficient thymic function indicate a favorable long-term immune reconstitution after cord blood stem cell transplantation. Blood 99: 1458-1464, 2002.

46. Wagner JE, Kurtzberg J: Cord blood stem cells. Curr Opin Hematol 4:413-418, 1997.

47. Wagner JE, Kernan NA, Steinbuch M, et al.: Allogeneic sibling umbilical-cord-blood transplantation in children with malignant and non-malignant disease. Lancet 346: 214-219, 1995.

48. Rocha V, Chastang C, Souillet G, et al.: Related cord blood transplants: the Eurocord experience from 78 transplants. Eurocord Transplant group. Bone Marrow Transplant 21(suppl 3):S59-S62, 1998.

49. Gluckman E, Rocha V, Boyer-Chammard A, et al.: Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group. N Engl J Med 337:373-381, 1997.

50. Gluckman E: Current status of umbilical cord blood hematopoietic stem cell transplantation. Exp Hematol 28:1197-1205, 2000.

51. Locatelli F, Rocha V, Chastang C, et al.: Factors associated with outcome after cord blood transplantation in children with acute leukemia. Eurocord-Cord Blood Transplant Group. Blood 93:3662-3671, 1999.

52. Kurtzberg J, Laughlin M, Graham ML, et al.: Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N Engl J Med 335: 157-166, 1996.

53. Wagner JE, Rosenthal J, Sweetman R, et al.: Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: analysis of engraftment and acute graft-versus-host disease. Blood 88:795-802, 1996.

54. Rubinstein P, Carrier C, Scaradavou A, et al.: Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med 339:1565-1577, 1998.

55. Gluckman E, Rocha V, Chastang C: European results of unrelated cord blood transplants. Eurocord Group. Bone Marrow Transplant 21(suppl 3):S87-S91, 1998.

56. Wagner JE, Barker JN, DeFor TE, et al.: Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood 100:1611-1618, 2002.

57. Rocha V, Cornish J, Sievers EL, et al.: Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood 97:2962-2971, 2001.

58. Michel G, Rocha V, Chevret S, et al.: Unrelated cord blood transplantation for childhood acute myeloid leukemia: a Eurocord Group analysis. Blood 102: 4290-4297, 2003.

59. Rocha V, Chastang C, Pasquini R, et al.: Cord blood transplant in patients with bone marrow failure syndromes. Blood 92:136a, 1998.

60. Howrey R, Martin P, Ciocci G: Unrelated cord blood transplantation for correction of genetic diseases. Blood 92:291a, 1998.

61. Ortega J, Yaniv L, Rocha V, et al.: Unrelated cord blood transplantation for inborn errors. Blood 1998:291a, 1998.

62. Ortega J, Rocha V, Wall D, et al.: Unrelated cord blood transplant in children with severe primary immunodeficiencies. An Eurocord analysis. Blood 98:667a, 2001.

63. Locatelli F, Rocha V, Reed W, et al.: Related umbilical cord blood transplantation in patients with tha-lassemia and sickle cell disease. Blood 101:2137-2143, 2003.

64. Staba SL, Escolar ML, Poe M, et al.: Cord-blood transplants from unrelated donors in patients with Hurler's syndrome. N Engl J Med 350:1960-1969, 2004.

65. Ooi J, Iseki T, Takahashi S, et al.: Unrelated cord blood transplantation for adult patients with advanced myelodysplastic syndrome. Blood 101:4711-4713, 2003.

66. Goldberg S, Chedid S, Jennis A, et al.: Unrelated umbilical cord blood transplantation in adults: a single institution experience. Blood 96:208a, 2000.

67. Cornetta K, Laughlin M, Carter S, et al.: Umbilical cord blood transplantation in adults: results of a prospective, multi-institutional, NHBLI sponsored trial. Blood 100: 42a, 2002.

68. Iseki T, Ooi J, Tomonari A, et al.: Unrelated cord blood transplantation in adults with hematological malignancy: a single institution experience. Blood 98:665a, 2001.

69. Gluckman E: Hematopoietic stem-cell transplants using umbilical-cord blood. N Engl J Med 344:1860-1861, 2001.

70. Laughlin MJ, Barker J, Bambach B, et al.: Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl J Med 344:1815-1822, 2001.

71. Sanz GF, Saavedra S, Planelles D, et al.: Standardized, unrelated donor cord blood transplantation in adults with hematologic malignancies. Blood 98:2332-2338, 2001.

72. Long GD, Laughlin M, Madan B, et al.: Unrelated umbilical cord blood transplantation in adult patients. Biol Blood Marrow Transplant 9:772-780, 2003.

73. Koh L, Chao NJ: Umbilical cord blood transplantation in adults using myeloablative and nonmyeloablative preparative regimens. Biol Blood Marrow Transplant 10(1):1-22, 2004.

74. Stiff P, Pecora A, Parthasarathy M, et al.: Umbilical cord blood transplants in adults using a combination of unexpanded and ex vivo expanded cells: preliminary clinical observations. Blood 92:646a, 1998.

75. Shpall E, Quinones R, Hami L, et al.: Transplantation of cancer patients receiving high dose chemotherapy with ex vivo expanded cord blood cells. Blood 92:646a, 1998.

76. Pecora A, Stiff P, Jennis A, et al.: Prompt and durable engraftment in two older adult patients with high risk chronic myelogenous leukemia (CML) using ex vivo expanded and unmanipulated unrelated cord blood. Bone Marrow Transplant 25:797-799, 2000.

77. Jaroscak J, Martin P, Waters-Pick B, et al.: A phase 1 trial of augmentation of unrelated umbilical cord blood transplantation with ex vivo expanded cells. Blood 92: 646a, 1998.

78. Barker J, Weisdorf D, DeFor T, et al.: Impact of multiple unit unrelated donor umbilical cord blood transplantation in adults: preliminary analysis of safety and efficacy. Blood 98:2791a, 2001.

79. Barker JN, Weisdorf DJ, DeFor TE, et al.: Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning. Blood 102:1915-1919, 2003.

80. Rizzieri DA, Long GD. Vredenburgh JJ, et al.: Successful allogeneic engraftment of mismatched unrelated cord blood following a nonmyeloablative preparative regimen. Blood 98:3486-3488, 2001.

81. McSweeney P: Nonmyeloablative allogeneic hematopoietic cell transplants: any role for rheumatoid arthritis?

J Rheumatol Suppl 64:49-54, 2001.

82. McSweeney P, Bearman S, Jones R, et al.: Nonmyeloablative hematopoietic cell transplants using cord blood. Blood 98:2794a, 2001.

83. Hwang W, Tan P, Goh Y, et al.: Minimal toxicity of an immunosuppression-based nonmyeloablative condition ing regimen for mismatched unrelated umbilical cord blood transplantation. Blood 100:5437a, 2002.

84. Cairo M, Harrison L, Del Toro G, et al.: Reduced intensity (RI) umbilical cord blood (UCB) and matched family donor (MFD) allogeneic stem cell transplantation (AlloSCT) in children and adolescents with malignant and nonmalignant disease. Blood 100:5432a, 2002.

85. Goggins T, Rizzieri DR: Nonmyeloablative allogeneic stem cell transplantation using alternative donors. Cancer Control 11:86-96, 2004.

0 0

Post a comment